Want to see CBIO full AI Analyst Report?
Crescent Biopharma (CBIO) Ownership Overview
9.33% Insiders
5.47% Mutual Funds
45.58% Other Institutional Investors
5.38% ETFs
34.24% Public Companies and
Individual Investors
The ownership structure of Crescent Biopharma (CBIO) stock is a mix of institutional, retail, and individual investors. Approximately 56.43% of the company’s stock is owned by Institutional Investors, 9.33% is owned by Insiders, and 34.24% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Dec 08, 2025 | xxxxxxxxxxxxx | $18237600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $3801525 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,747,866 | Institution | 7.70% | 40,531,024 | |
| 2,747,866 | Insider | 7.70% | 40,531,024 | |
| 956,513 | Institution | 2.68% | 14,108,567 | |
| 805,077 | Institution | 2.26% | 11,874,886 | |
| 780,782 | Institution | 2.19% | 11,516,535 | |
| 466,381 | Institution | 1.31% | 6,879,120 | |
| 302,457 | Institution | 0.85% | 4,461,241 | |
| 281,212 | Insider | 0.79% | 4,147,877 | |
| 251,090 | Institution | 0.70% | 3,703,578 | |
| 221,065 | Institution | 0.62% | 3,260,709 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 780,782 | Institution | 2.19% | 11,516,535 | |
| 466,381 | Institution | 1.31% | 6,879,120 | |
| 251,090 | Institution | 0.70% | 3,703,578 | |
| 221,065 | Institution | 0.62% | 3,260,709 | |
| 113,421 | Institution | 0.32% | 1,672,960 | |
| 74,714 | Institution | 0.21% | 1,102,032 | |
| 12,607 | Institution | 0.04% | 185,953 | |
| 8,300 | Institution | 0.02% | 122,425 | |
| 8,006 | Institution | 0.02% | 118,089 | |
| 7,409 | Institution | 0.02% | 109,283 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 661,946 | Institution | 1.86% | 11,915,028 | |
| 530,951 | Institution | 1.49% | 7,831,527 | |
| 201,242 | Institution | 0.56% | 2,968,320 | |
| 124,281 | Institution | 0.35% | 2,237,058 | |
| 83,801 | Institution | 0.23% | 1,508,418 | |
| 72,884 | Institution | 0.20% | 1,075,039 | |
| 39,408 | Institution | 0.11% | 709,344 | |
| 38,440 | Institution | 0.11% | 580,828 | |
| 23,282 | Institution | 0.07% | 419,076 | |
| 22,821 | Institution | 0.06% | 344,825 |
FAQ
Who Owns Crescent Biopharma (CBIO)?
According to the latest TipRanks data, approximately 45.58% of the company's stock is held by institutional investors, 9.33% is held by insiders, and 34.24% is held by retail investors.
What percentage of Crescent Biopharma (CBIO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 45.58% of Crescent Biopharma (CBIO) stock is held by institutional investors.
What percentage of Crescent Biopharma (CBIO) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.24% of Crescent Biopharma (CBIO) stock is held by retail investors.
Who owns the most shares of Crescent Biopharma (CBIO)?
Peter Harwin owns the most shares of Crescent Biopharma (CBIO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.